The expert source of drug information in palliative and hospice care

The Palliative Care Formulary provides unrivalled and expert drug information for health professionals when caring for adult patients facing progressive life-limiting diseases. This trusted source goes beyond standard references providing health professionals with in-depth and practical guidance on drugs and treatment regimens to help improve quality of life.

SubscribeContent Updates
Features and Benefits icon

Internationally acclaimed with over 20 years of unrivalled in-depth knowledge

Features and Benefits icon

Independent information on general and specialist drug use in palliative care

 

Features and Benefits icon

Comprehensive guidance for use across all stages of the patient journey

Features and Benefits icon

Rigorously researched information grounded firmly in everyday clinical practice

Publication Updates

10 Nov
Palliative Care Formulary November 2020 Update

This update contains 2 revised monographs.

The following monographs have been fully revised: Drugs for diabetes mellitus; Oxcarbazepine.

13 Oct
Palliative Care Formulary October 2020 Update

This update contains 2 revised monographs.

The following monographs have undergone minor revision: Anaphylaxis; Melatonin.

 

08 Sep
Palliative Care Formulary September 2020 Update

This update contains 2 revised monographs.

The following monographs have undergone minor revision: Inhaled long-acting β2 agonists (LABAs); Strong opioids.

 
11 Aug
Palliative Care Formulary August 2020 Update

This update contains 2 revised monographs.

The following monographs have been fully revised: Cerumenolytics; Drugs for oral inflammation and ulceration.

14 Jul
Palliative Care Formulary July 2020 Update

This update contains 4 revised monographs and a revision to the preface.

The following monographs have been fully revised: Artificial saliva; Continuous subcutaneous drug infusions; Oral nutritional supplements; Pilocarpine.

09 Jun
Palliative Care Formulary June 2020 Update

This update contains 1 new monograph, 22 revised monographs and 6 discontinued monographs. Editorial Staff was a new monograph for this update.

The following monographs have been fully revised:

Abbreviations; Anaphylaxis; Barrier products; Demeclocycline; Drug-induced movement disorders; Drugs for pruritus; Emollients; *Ketamine; Nebulized drugs; Obtaining specials; *Octreotide; Potassium; Prescribing in children; Prescribing in palliative care; Systemic corticosteroids; Taking controlled and prescription drugs to other countries; Topical antipruritics; Urinary tract infections; Variability in response to drugs.

The following monographs have undergone minor revision:

Getting the most out of PCF; How PCF is constructed; Prolongation of the QT interval in palliative care.

The following monographs have been discontinued:

Cardiovascular system (introductory paragraph); Clostridium difficile infection; Flurbiprofen; Nabumetone; Orphenadrine; Prochlorperazine.

View more View all content updates